Emorya Finance is projected to decline to $0.0001956 by 2027, a -35% move from its current price of $0.0003009. EMR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 6/8/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $0.0002772 | $0.0003007 | $0.0003261 | -0.06% |
| Aug 4 | $0.0002679 | $0.0003005 | $0.0003371 | -0.12% |
| Aug 5 | $0.0002609 | $0.0003003 | $0.0003457 | -0.18% |
| Aug 6 | $0.0002551 | $0.0003001 | $0.0003531 | -0.24% |
| Aug 7 | $0.0002502 | $0.00030 | $0.0003597 | -0.30% |
| Aug 8 | $0.0002457 | $0.0002998 | $0.0003658 | -0.36% |
| Aug 9 | $0.0002417 | $0.0002996 | $0.0003714 | -0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.0002417 | $0.0002996 | $0.0003714 | -0.41% |
| Week 2 | $0.0002202 | $0.0002984 | $0.0004043 | -0.83% |
| Week 3 | $0.0002048 | $0.0002971 | $0.0004311 | -1.24% |
| Week 4 | $0.0001925 | $0.0002959 | $0.0004548 | -1.65% |
| Week 5 | $0.0001823 | $0.0002947 | $0.0004765 | -2.05% |
| Week 6 | $0.0001734 | $0.0002935 | $0.0004967 | -2.46% |
| Week 7 | $0.0001655 | $0.0002922 | $0.000516 | -2.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Emorya is an innovative platform that combines sports and blockchain technology to provide users with a unique and rewarding experience. Through the Emorya mobile application, individuals can pursue better health and financial success, earning a virtual currency called $EMRS by tracking calories burned throughout the day.
Emorya thrives on the MultiversX Blockchain, where two tokens, $EMRS and $EMR, work together within the ecosystem. The $EMRS coin holds an intrinsic value of 30% of the market capitalization attributed to the $EMR coin, and EMRS can be converted to EMR via the app with a 3% conversion fee.
The first Hyper Deflationary concept limits supply to 1 Million, and the STOP Burn concept halts EMR burn functions when the total EMR supply reaches 1 Million, making EMR more rare and valuable. The program envisions worldwide opportunities to enhance prosperity while living an active lifestyle.
Emorya Finance (EMR) is currently priced at $0.0003009 and sits in the 4399th spot by market capitalization, with a market cap of $247.08K.
All-time high is $0.0446 and all-time low is $0.0002307, showing a wide historical range relative to the current price. The forecast suggests a mixed long-run outlook, with modest to strong upside possible in select years (notably 2032, 2035, 2040, and 2050) but with volatility and drawdowns in others.
In the near term, the 30-day technical picture remains neutral, while later years show a path to higher averages. For 2040 and 2050, the model projects avg prices of $0.000478 and $0.0009134 respectively, with corresponding ROIs of 58.9% and 203.6%.
A major floor 81.7% below — a decisive break under it would weaken the trend.
The nearest floor, 68.5% below — buyers have tended to step in here.
Resistance now sits 42.6% below — it may act as fresh support.
A major ceiling 48.4% above — clearing it would confirm fresh momentum.
Key EMR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EMR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0001327 | Buy | $0.0001324 | Buy |
| MA 10 | $0.0001295 | Buy | $0.0001296 | Buy |
| MA 20 | $0.0001228 | Buy | $0.0001296 | Buy |
| MA 50 | $0.000156 | Buy | $0.00017 | Buy |
| MA 100 | $0.0002611 | Buy | $0.0002933 | Buy |
| MA 200 | $0.0005571 | Sell | $0.0007269 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 48.37 | Neutral |
| Stoch RSI (14) | 72.07 | Neutral |
| CCI (20) | 70.07 | Neutral |
| Williams %R (14) | -26.06 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 12.93 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 73.94 | Neutral |
| TRIX (15) | -1.06 | Sell |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 57.02 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 14.61 | Neutral |
| ATR (14) | 0.00 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The market is hovering around a minor consolidation phase. The price currently sits near the 50-day average of $0.0002936, while the 200-day average sits higher at $0.0008344.
Key support is at $0.0001494 and resistance at $0.0003504. Over the last 30 days, the range has traded from a low of $0.0001806 to a high of $0.0005013, indicating range-bound activity with potential for short-term moves within these levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.00009478 | $0.0003009 | $0.0003009 | 0% | Neutral | |
| $0.0001423 | $0.0001956 | $0.0002904 | -35% | Bearish | |
| $0.0002337 | $0.0003416 | $0.0005412 | +14% | Neutral | |
| $0.0002232 | $0.0003437 | $0.0005721 | +14% | Neutral | |
| $0.00016 | $0.0002585 | $0.000448 | -14% | Neutral | |
| $0.0001134 | $0.0001914 | $0.0003436 | -36% | Bearish | |
| $0.0002619 | $0.0004614 | $0.0008542 | +53% | Bullish | |
| $0.0002081 | $0.0003818 | $0.0007267 | +27% | Bullish | |
| $0.00008451 | $0.0001614 | $0.0003149 | -46% | Bearish | |
| $0.0002301 | $0.0004569 | $0.0009126 | +52% | Bullish | |
| $0.0002237 | $0.0004971 | $0.001092 | +65% | Bullish | |
| $0.0004026 | $0.0008946 | $0.002058 | +197% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.00009478 | $0.0003009 | $0.000338 | +0.00% |
| September 2026 | $0.0002394 | $0.0002916 | $0.0003707 | -3.09% |
| October 2026 | $0.0002309 | $0.000285 | $0.0003696 | -2.24% |
| November 2026 | $0.0001793 | $0.0002238 | $0.0002949 | -21.46% |
| December 2026 | $0.0001516 | $0.0001912 | $0.0002555 | -14.59% |
Click any year to see its month-by-month EMR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, EMR is projected to trade between $0.00009478 and $0.0003009, averaging $0.0003009 — a potential gain of 0% from today's $0.0003009. A consolidation phase looks the most probable path here.
Emorya Finance's 2027 outlook centres on $0.0001956, within a $0.0001423 to $0.0002904 range. That is -35% versus the projected 2026 average. That marks a -35% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2028, EMR could reach as high as $0.0005412, with a base case around $0.0003416 and support toward $0.0002337 — roughly +14% from $0.0003009. A consolidation phase looks the most probable path here.
Expect EMR to range from $0.0002232 to $0.0005721 through 2029. The $0.0003437 average target implies a +14% move from current prices. That is up +1% on the projected 2028 average. Price action looks broadly range-bound.
The EMR price prediction for 2030 points to an average of $0.0002585 (low $0.00016, high $0.000448) — a potential decline of -14% on today's $0.0003009. A consolidation phase looks the most probable path here.
In 2031, EMR is projected to trade between $0.0001134 and $0.0003436, averaging $0.0001914 — a potential decline of -36% from today's $0.0003009. That is -26% versus the projected 2030 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Emorya Finance's 2032 outlook centres on $0.0004614, within a $0.0002619 to $0.0008542 range. That is up +141% on the projected 2031 average. That marks a +53% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, EMR could reach as high as $0.0007267, with a base case around $0.0003818 and support toward $0.0002081 — roughly +27% from $0.0003009. Momentum favours further upside here.
Expect EMR to range from $0.00008451 to $0.0003149 through 2034. The $0.0001614 average target implies a -46% move from current prices. That is -58% versus the projected 2033 average. Expect choppier, lower action through this leg of the cycle.
The EMR price prediction for 2035 points to an average of $0.0004569 (low $0.0002301, high $0.0009126) — a potential gain of +52% on today's $0.0003009. Momentum favours further upside here.
In 2040, EMR is projected to trade between $0.0002237 and $0.001092, averaging $0.0004971 — a potential gain of +65% from today's $0.0003009. That is up +9% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Emorya Finance's 2050 outlook centres on $0.0008946, within a $0.0004026 to $0.002058 range. That is up +80% on the projected 2040 average. That marks a +197% change versus current levels. Momentum favours further upside here.
Investing $1,000 in EMR today (≈ 3,323,805.092069 EMR) could be worth
$2,973.44
+$1,973.44 (+197%) by 2050 · US Dollar
Based on the average projected EMR price of $0 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EMRwould be worth at today's price.
$1,000 invested in EMR on Aug 1, 2025 (≈ 344,310.337056 EMR) would be worth
$103.59
-$896.41 (-89.6%) today · 0.10× · US Dollar
Based on a EMR entry price of $0.002904 vs. today's $0.000301.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.000126 | $2,392.45 | +139.2% |
| 1 month ago | $0.000147 | $2,040.87 | +104.1% |
| 3 months ago | $0.000431 | $698.61 | -30.1% |
| 6 months ago | $0.000991 | $303.55 | -69.6% |
| 1 year ago | $0.002904 | $103.59 | -89.6% |
| All time (1.2y) ago | $0.007586 | $39.66 | -96.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EMR forecast.
Our base-case forecast reaches $0.00060 around 2050.
Implied market cap at $0.00060: $492.82K
The multi-year forecast shows mixed but asymmetric upside over time. In 2026, the min, avg, and max are $0.0001494, $0.0003009, and $0.0003009 with zero ROI. 2027 is bearish with min $0.0001316, avg $0.0001818, max $0.0002717 and ROI -39.6%.
Bullish signals appear in 2028 (avg $0.0003627, ROI 20.6%) and 2032 (avg $0.0005036, ROI 67.4%). The 2030 projection shows a negative path (avg $0.0002133, ROI -29.1%), followed by continued bearishness in 2031 (avg $0.000214, ROI -28.9%). Longer horizon upside is evident in 2040 (avg $0.000478, ROI 58.9%) and 2050 (avg $0.0009134, ROI 203.6%).
The series includes a wide range of outcomes, with max forecast values reaching $0.0003709 in 2030 and $0.002101 in 2050, underscoring substantial volatility. Overall, the forecast implies notable long-run upside but paired with considerable downside risk in several years.
Tap a question to reveal the answer.
2030 min $0.0001315, avg $0.0002133, max $0.0003709; ROI -29.1%; sentiment BEARISH.
Yes, the 2035 max is $0.001065, with 2035 avg $0.0005324 and ROI 77%, indicating potential upside in that year.
Forecasts show mixed momentum: bearish years like 2027 (-39.6% ROI) and 2030 (-29.1%) contrast with bullish years such as 2032 (ROI 67.4%), 2035 (77%), 2040 (58.9%), and 2050 (203.6%). These are estimates, not guarantees.
EMRS is earned by tracking calories burned; it can be converted to EMR via the app with a 3% conversion fee. The $EMRS coin holds an intrinsic value of 30% of the market capitalization attributed to the $EMR coin.
All-time high is $0.0446 and all-time low is $0.0002307.
Emorya Finance Community Discussion
0Share your Emorya Finance price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.